Comparative evaluation of the effectiveness and safety of 12-hour and 21-hour protocols for the administration of acetylcysteine in paracetamol poisoning
https://doi.org/10.24884/2078-5658-2022-20-4-46-53
Abstract
Background. Acetylcysteine (ACC) is an effective antidote for paracetamol poisoning. There are various schemes for its application. At the same time, there is currently no information about the most priority of them in this pathology. Few studies indicate the effectiveness of the 12-hour protocol for ACC administration in paracetamol poisoning. However, there were not enough justifications for the introduction of a modified 12-hour scheme into world practice.
The objective was to compare the effectiveness of the 12-hour and 21-hour protocols for the administration of acetylcysteine in paracetamol poisoning.
Materials and methods. 43 patients with acute paracetamol poisoning were examined. The study group (prospective) consisted of 23 patients who underwent the 12-hour ACC protocol; the comparison group (retrospective) with the 21-hour ACC protocol included 20 patients. Groups were comparable. The endpoints were: ALT blood level, the frequency of allergic reactions, the duration of treatment in the ICU, the duration of stay in the hospital.
Results. The 12-hour and 21-hour protocols for intravenous administration of ACC in case of paracetamol poisoning are equally effective in preventing liver damage, as evidenced by the results of the study: in both groups, when the antidote was started early (in the first 8 hours), there was no increase in ALT levels. The use of the 12-hour protocol for intravenous administration of ACC leads to a reduction in the duration of stay in the ICU by 1.5 times (p = 0.001), the duration of hospital treatment by 1.3 times (p = 0.052) compared to the 21-hour protocol. The frequency of allergic reactions during the 21-hour protocol of ACC administration was 10%; with the 12-hour ACC scheme, no allergic reactions were noted.
Conclusions. The data obtained show that both protocols for the administration of ACC, when used early, are equally effective in preventing toxic liver damage, while the administration of ACC according to the 12-hour protocol leads to fewer adverse reactions, a reduction in the duration of stay in the ICU and the duration of hospitalization.
About the Authors
A. Yu. SimonovaRussian Federation
Simonova Anastasia Yu. Cand. of Sci. (Med.), Leading Research Fellow of the Department of Acute Poisonings and Somatopsychiatric Disorders, N.V. Sklifosovsky Research Institute for Emergency Medicine, Assistant of the Department of Clinical Toxicology, Russian Medical Academy of Continuous Professional Education, Leading Research Fellow, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical and Biological Agency
Bolshaya Sukharevskaya sq., Moscow, 107045
2/1, bldg. 1, Barrikadnaya str., Moscow, 125993
1a, Malaya Pirogovskaya STR., Moscow, 119435
M. M. Potskhveriya
Russian Federation
Potskhveriya Michael M. Cand. of Sci. (Med.), Head of the Scientific Department of Acute Poisoning and Somatopsychiatric Disorders,
N. V. Sklifosovsky Research Institute for Emergency Medicine, Associate Professor of the Department of Clinical Toxicology, Russian Medical Academy of Continuous Professional Education
Bolshaya Sukharevskaya sq., Moscow, 107045
2/1, bldg. 1, Barrikadnaya str., Moscow, 125993
M. V. Belova
Russian Federation
Belova Maria V. Dr. of Sci. (Biol.), Leading Research Fellow of the Department of Acute Poisonings and Somatopsychiatric Disorders, N.V. Sklifosovsky Research Institute for Emergency Medicine, Associate Professor of the Department of Clinical Toxicology, Russian Medical Academy of Continuous Professional Education
Bolshaya Sukharevskaya sq., Moscow, 107045
2/1, bldg. 1, Barrikadnaya str., Moscow, 125993
K. K. Ilyashenko
Russian Federation
Ilyashenko Kapitalina K. Dr. of Sci. (Med.), Professor, Scientific Consultant of the Department of Acute Poisonings and Somatopsychiatric Disorders, N.V. Sklifosovsky Research Institute for Emergency Medicine, Leading Research Fellow, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical and Biological Agency
3, Bolshaya Sukharevskaya sq., Moscow, 107045
1a, Malaya Pirogovskaya STR., Moscow, 119435
V. V. Kulabukhov
Russian Federation
Kulabukhov Vladimir V. Cand. of Sci. (Med.), Leading Research Fellow of the Department of Emergency Surgery, Endoscopy and Intensive Care, N. V. Sklifosovsky Institute for Emergency Medicine
3, Bolshaya Sukharevskaya sq., Moscow, 107045
L. R. Asanova
Russian Federation
Asanova Lola R. Junior Research Fellow of the Department of Acute Poisoning and Somatopsychiatric Disorders, N. V. Sklifosovsky Research Institute for Emergency Medicine
3, Bolshaya Sukharevskaya sq., Moscow, 107045
References
1. Akalaev R.N., Sharipova V.Kh., Stopnitskiy A.A., Khozhiev Kh.Sh. Assessment of effect of chronic alcohol intoxication on certain parameters of the autonomic nervous system and cognitive functions. Messenger of Anesthesiology and Resuscitation, 2020, vol. 17, no. 3, pp. 32–38. Doi: 10.21292/2078-5658-2020-17-3-32-38. (In Russ.)
2. Belova M.V., Ilyashenko K.K., Simonova A.Yu., Potskhveriya M.M., Trusov G.V. The structure of acute exotoxicosis during the first three months of the COVID-19 pandemic (according to the acute toxicosis department of N.V. Sklifosovsky Research Institute for Emergency Medicine). Emergency Medical Care, 2021, vol. 10, no. 1, pp. 27–32. Doi: 10.23934/2223-9022-2021-10-1- 27-32. (In Russ.)
3. Il’yashenko K.K., Simonova A.Yu., Belova M.V. A structural analysis of acute exotoxicoses in people of elderly and senile age. Toxicological Review, 2017, vol. 1, no. 142, pp. 10–14. Doi: 10.36946/0869-7922-2017-1-10-14. (In Russ.)
4. Simonova A.Yu., Potskhveriya M.M., Belova M.V. et al. On the Treatment of Acute Poisoning with Paracetamol. Emergency Medical Care, 2022, vol. 11, no. 2, pp. 249–257. Doi: 10.23934/2223-9022-2022-11-2-249-257. (In Russ.)
5. Simonova A.Yu., Potskhveriya M.M., Belova M.V. et al. Modification of antidote therapy for poisoning due to massive admission of paracetamol. Transplantologiya. The Russian Journal of Transplantation, 2022, vol. 14, no. 4, pp. 444–451.
6. Simonova A.Yu., Potskhveriya M.M., Belova M.V. et al. Modification of antidotetherapy for poisoning due to massive admission of paracetamol. Transplantologiya. The Russian Journal of Transplantation, 2022, vol. 14, no. 4, pp. 444–451. (In Russ.) Doi: 10.23873/2074-0506-2022-14-4- 444-451.
7. Udal’cov M.A, Pshenisnov K.V., Аleksаndrovich Yu.S., Kаziаkhmedov V.А. Acute methadone poisoning in children: diagnosis and treatment. Messenger of Anesthesiology and Resuscitation, 2020, vol. 17, no. 5, pp. 31–39. Doi: 10.21292/2078-5658-2020-17-5-31-39.
8. Cairney D.G., Beckwith H.K., Al-Hourani K. et al. Plasma paracetamol concentration at hospital presentation has a dose-dependent relationship with liver injury despite prompt treatment with intravenous acetylcysteine. Clin. Toxicol. (Phila), 2016, vol. 54, no. 5, pp. 405–410. Doi: 10.3109/15563650.2016.1159309.
9. Chiew A.L., Gluud C., Brok J. et al. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev., 2018, vol. 2, no. 2, pp. CD003328. Doi: 10.1002/14651858.CD003328.pub3.
10. Chiew A.L., Isbister G.K., Kirby K.A. et al. Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2). Clin. Toxicol. (Phila), 2017, vol. 55, no. 10, pp. 1055–1065. Doi: 10.1080/15563650.2017.1334915.
11. Clark R., Fisher J.E., Sketris I.S. et al. Population prevalence of high dose paracetamol in dispensed paracetamol/opioid prescription combinations: an observational study. BMC Clin Pharmacol., 2012, vol. 12, pp. 11. Doi: 10.1186/1472-6904-12-11.
12. Medical Toxicology / Eds. by R.C. Dart. 3rd ed. Lippincott Williams & Wilkins, 2004, 2304 p.
13. Harrison P.M., Keays R., Bray G.P. et al. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet, 1990, vol. 335, no. 8705, pp. 1572–1573. Doi: 10.1016/0140-6736(90)91388-q.
14. Heard K., Rumack B.H., Green J.L. et al. A single-arm clinical trial of a 48-hour intravenous N-acetylcysteine protocol for treatment of acetaminophen poisoning. Clin Toxicol (Phila), 2014, vol. 52, no. 5, pp. 512–518. Doi: 10.3109/15563650.2014.902955.
15. Humphries C., Roberts G., Taheem A. et al. SNAPTIMED study: does the Scottish and Newcastle Antiemetic Protocol achieve timely intervention and management from the emergency department to discharge for paracetamol poisoning? Emerg. Med. J., 2023, vol. 40, no. 3, pp. 221–223. Doi: 10.1136/emermed-2021-212180.
16. Pettie J.M., Caparrotta T.M., Hunter R.W. et al. Safety and efficacy of the SNAP 12-hour acetylcysteine regimen for the treatment of paracetamol overdose. EClinical Medicine, 2019, vol. 11, pp. 11–17. Doi: 10.1016/j. eclinm.2019.04.005.
17. Wong A., Graudins A. Simplification of the standard three-bag intravenous acetylcysteine regimen for paracetamol poisoning results in a lower incidence of adverse drug reactions. Clin. Toxicol. (Phila), 2016, vol. 54, no. 2, pp. 115–119. Doi: 10.3109/15563650.2015.1115055.
Review
For citations:
Simonova A.Yu., Potskhveriya M.M., Belova M.V., Ilyashenko K.K., Kulabukhov V.V., Asanova L.R. Comparative evaluation of the effectiveness and safety of 12-hour and 21-hour protocols for the administration of acetylcysteine in paracetamol poisoning. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2023;20(4):46-53. (In Russ.) https://doi.org/10.24884/2078-5658-2022-20-4-46-53